| LP417753-3 | Reaction wheal^2D post control ID | COMPONENT | 1 |
| LP417754-1 | Reaction wheal | COMPONENT | |
| LP417755-8 | 1 day post dose control intradermal | CHALLENGE | |
| LP417756-6 | 2 day post dose control intradermal | CHALLENGE | |
| LP417757-4 | Delayed hypersensitivity anergy panel | COMPONENT | 1 |
| LP417761-6 | Last ate or drank anything other than plain water | COMPONENT | 1 |
| LP417762-4 | VEGFA gene targeted mutation analysis | COMPONENT | 1 |
| LP417763-2 | VEGFA gene | COMPONENT | |
| LP417765-7 | Dermatan sulfate, heparan sulfate, chondroitin-6-sulfate, keratan sulfate panel | COMPONENT | 1 |
| LP417766-5 | Chondroitin-6-sulfate | COMPONENT | |
| LP417802-8 | Voltage-gated calcium channel PQ type binding Ab.IgG+IgM | COMPONENT | 1 |
| LP417803-6 | Purkinje cell cytoplasmic type 2 Ab.IgG | COMPONENT | 2 |
| LP417804-4 | 2,3-dinor 11 beta-Prostaglandin F2 alpha/Creatinine | COMPONENT | 2 |
| LP417805-1 | Neuronal nuclear type 1 Ab.IgG | COMPONENT | 4 |
| LP417806-9 | Glutamate decarboxylase 65 IgG+IgM | COMPONENT | 2 |
| LP417807-7 | Neuronal nuclear type 3 Ab.IgG | COMPONENT | 2 |
| LP417808-5 | Candida glabrata RNA | COMPONENT | 1 |
| LP417809-3 | Candida albicans+dubliniensis+parapsilosis+tropicalis RNA | COMPONENT | 1 |
| LP417826-7 | Pelvis and Hip - unilateral | SYSTEM | 1 |
| LP417828-3 | View and Views supine and upright and lateral-decubitus | COMPONENT | 1 |
| LP417830-9 | Exposure source in 30 days prior to onset of illness | COMPONENT | 1 |
| LP417834-1 | Voltage-gated calcium channel N type binding IgG+IgM | COMPONENT | 1 |
| LP417850-7 | Bone Marrow Transplant | METHOD | 7 |
| LP417851-5 | Bone Marrow Transplant | Document.SubjectMatterDomain | 7 |
| LP417852-3 | Solid organ transplant | Document.SubjectMatterDomain | 9 |
| LP417854-9 | Solid Organ Transplant | METHOD | 9 |
| LP417855-6 | Creatinine and Cystatin C-based formula (CKD-EPI) | METHOD | |
| LP417860-6 | SLC25A15 gene c.562_564delTTC | COMPONENT | 1 |
| LP417864-8 | SARS-related coronavirus+MERS coronavirus RNA | COMPONENT | 1 |
| LP417865-5 | SARS-related coronavirus+MERS coronavirus | COMPONENT | |
| LP417866-3 | SARS-related coronavirus | COMPONENT | |
| LP417867-1 | SARS-related coronavirus RNA | COMPONENT | 2 |
| LP417868-9 | Gleason scoring basis | COMPONENT | 1 |
| LP417869-7 | Prostate cancer grade group basis | COMPONENT | 1 |
| LP417871-3 | Prostate tumor area with Gleason pattern 4+5/Total tumor area | COMPONENT | 1 |
| LP417872-1 | Tissue block identifier | COMPONENT | 1 |
| LP417873-9 | ADRB2 gene | COMPONENT | |
| LP417874-7 | AGTR1 gene c.1166A>C | COMPONENT | 1 |
| LP417875-4 | Biopsy site | COMPONENT | 1 |
| LP417876-2 | Intraductal carcinoma of prostate | COMPONENT | 1 |
| LP417880-4 | Prostate tumor area with Gleason pattern 4+5 | COMPONENT | |
| LP417881-2 | High grade prostatic intraepithelial neoplasia | COMPONENT | 1 |
| LP417882-0 | Granulomatous prostatitis | COMPONENT | 1 |
| LP417883-8 | Staphylococcus aureus and Methicillin Resistant Staphylococcus aureus | COMPONENT | 1 |
| LP417884-6 | Prostate cancer grade group | COMPONENT | 1 |
| LP417885-3 | Bovine diarrhea virus subtype | COMPONENT | 1 |
| LP417886-1 | Pasteurella multocida toxin toxA gene | COMPONENT | 1 |
| LP417887-9 | Mannheimia haemolytica | COMPONENT | |
| LP417888-7 | Ureaplasma diversum | COMPONENT | |
| LP417889-5 | Ureaplasma diversum DNA | COMPONENT | 1 |